+218.1%
MRNA vs AMC
-59.1%
+277.3%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.7% | -0.8% | -2.9% |
| 7D | -12.1% | +3.5% | -15.6% | -12.7% |
| 30D | -1.3% | +12.5% | -13.8% | -3.0% |
| 3M | +250.9% | +23.6% | +227.4% | +238.3% |
| 6M | +343.0% | +144.4% | +198.7% | +279.0% |
| YTD | +657.4% | +108.3% | +549.1% | +553.7% |
| 1Y | +794.9% | +38.9% | +756.0% | +719.8% |
| 3Y | +218.1% | -58.9% | +277.0% | +261.4% |
| All | +218.1% | -59.1% | +277.3% | +261.4% |
Cumulative growth
Daily Returns
Daily percentage return beside AMC.
Daily Out/Under-Performance
Portfolio return minus AMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling